Cellerix is operational since 2002 and was formally founded in 2004 as part of the Genetrix Group. Cellerix is a Cell Therapy Company with sharp clinical focus and maintains a solid product pipeline, targeting main indications for fistula treatment and skin regeneration. Cellerix is a biotechnology company actively developing and producing innovative medicines based on the use of stem cells of adult origin. The company is engaged in clinical PhaseII trials for the treatment of complex perianal fistulas.
R&D
To view this information, you must subscribe to Partneringtools.
Partnerships
To view this information, you must subscribe to Partneringtools.
Senior management
To view this information, you must subscribe to Partneringtools.
Head office
To view this information, you must subscribe to Partneringtools.
Industry news: Pharmalicensing provides comprehensive industry coverage.